UK markets closed

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2900-0.0500 (-2.14%)
At close: 04:00PM EDT
2.2200 -0.07 (-3.06%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-22,555
-22,555
-21,198
-18,457
-8,445
Depreciation & amortisation
31
31
32
43
20
Stock-based compensation
1,473
1,473
1,506
1,157
430
Change in working capital
4,939
4,939
-1,167
-1,283
61
Accounts payable
296
296
2,577
3,025
30
Other working capital
-16,118
-16,118
-20,834
-18,567
-8,030
Net cash provided by operating activities
-16,112
-16,112
-20,827
-18,540
-7,934
Cash flows from investing activities
Investments in property, plant and equipment
-6
-6
-7
-27
-96
Net cash used for investing activities
-6
-6
-7
-27
-96
Cash flows from financing activities
Common stock issued
1,049
1,049
3,199
17,371
25,160
Dividends paid
-201
-201
-201
-201
-201
Net cash used provided by (used for) financing activities
848
848
2,998
21,737
29,504
Net change in cash
-14,967
-14,967
-18,214
3,153
21,521
Cash at beginning of period
18,345
18,345
36,559
33,406
11,885
Cash at end of period
3,378
3,378
18,345
36,559
33,406
Free cash flow
Operating cash flow
-16,112
-16,112
-20,827
-18,540
-7,934
Capital expenditure
-6
-6
-7
-27
-96
Free cash flow
-16,118
-16,118
-20,834
-18,567
-8,030